Objective: Advances in choledochoscopy technology lead to an improvement in the diagnosis and treatment of hepatopancreatobiliary diseases. The aim of this study is to reveal the role of choledochoscopy in hepatopancreatobiliary pathologies.
Introduction
Many medical records determined that biliary stones were known and treated from the ancient times [1, 2] . The revolution of the diagnosis and treatment in medical sciences was experienced with the application of fiberoptic technology since 1960's [3] . Technology was started to scan gastrointestinal system, and than choledoch, one of the narrowest channels of the body, was visualised by the endoscopes. After the first experience of Kawai et al. [4] in optic system and mobilisation capability of the endoscopes made the choledochoscopy as valuable method in the diagnosis and treatment of hepatopancreatobiliary system diseases [5] [6] [7] [8] .
The aim of this study is to evaluate the results of 235 intraoperative flexible choledochoscopy procedures performed in a 25-year period between July 1998 and July 2013.
Materials and Methods
In Atatürk University, School of Medicine, Department of General Surgery, 235 intraoperative flexible choledochoscopy procedures were performed in the period above mentioned. Age, gender, indications, addictive diagnostic and therapautic endoscopic procedures, choledochoscopy time, diagnosis, mortality and morbidity were evaluated retrospectively. Endoscopic procedures performed in patients, in whom general anesthesia and open surgical procedures due to hepatobiliary system disorders were performed in the operation rooms. Olympus CHF T 20 flexible choledochoscope and related instruments, including electrocoagulators, balloon and bascet catheters, lithotriptors, biopy and sitology forceps, and other devices were used.
Results
In this study 235 patients included with a mean age of 63.1 years (range: 19-92 years). Of the patients, 148 (63.0%) were female, and 87 (37.0%) were male.
The most common indications of choledochoscopy were suspected common bile duct stone in 96 patients (40.9%), serum cholestatic enzyme increase without jaundice in 52 (22.1%), obstructive jaundice and/or serum bilirubin increase in 46 (19.6%), and presence of dilated choledoch in 42 (17.9%), as shown in Table 1 . Additional diagnostic and therauputic procedures were applicated 156 times in 125 patients; stone extraction in 87 patients (37.0%), biopsy in 25 (10.6%), hydatid cyst vesicules extraction in 12 (5.1%), balloon dilatation in 10 (4.3%), brushing cytology in 8 (3.4%), stent extraction in 8 (3.4%), and stent application in 6 (2.6%). Mean choledochoscopy time was 8.5 minutes (range: 5-25 minutes, excluding the choledochotomy and closure times). As seen in In this series, mortality was not seen due to the endoscopic procedures. A choledochal tear in choledochotomy line, as a complication, occured in 4 patients (1.7%), and these patients were treated by primary closure.
Discussion
In spite of the surgeons remarkable efforts, the residual biliary stone incidence is still high [9, 10] . On the other hand, not only the biliary stones, but also papilla tumors and stenosis, choledoch tumors, cysts and parasites, liver tumors and cysts, and pancreas tumors and cycts, which are the major hepatopancreatobiliary patologies, make the choledochoscopy important [10] [11] [12] .
Although cholestasis, with or without jaundice, is one of the major indications of MRCP or ERCP, intraoperative choledochoscopy is an alternative diagnostic and therapeutic method, particularly in patients in whom MRCP or ERCP is not performed, inadequate, or unsuccessful [3, [6] [7] [8] , as was in our study. Choledoch stones, as well as the residual biliary stones, are the most important factors that affect the cost effectivity, mortality, and morbidity in patients with biliary system stones, which are benign diseases [3, 13, 14] . MRCP and ERCP have some restrictions; MRCP is not a therapeutic procedure in addition to its 28% of false negativity and 11% of false positivity diagnostic rates for biliary system stones [3, [6] [7] [8] , while ERCP is an invasive procedure, even if minimal, with a mean 15% of complication rate in addition to its 5-20% of impossible cannulation rate [3, 15] . Additionally, to palpate or to determine the choledoch stones during laparoscopic surgery is difficult, even if possible, so it is important to diagnose them before surgery. Similarly, a mean 10% of false negative visualization or exploration rate of choledochal stones during open or laparoscopic surgery may create need for choledochoscopy for the biliary system stones [3, 7, [16] [17] [18] [19] [20] . In intraoperative choledochoscopy, the stones or stone particles can be directly seen, as well as the stones are easily differantiated from blood cougulum or air bubbles [3, 11] . Additionally, electrohidrolic or laser lithotripsy can be performed by this technique [3, 18, [21] [22] [23] [24] [25] [26] [27] . On the other hand, some other major application areas of choledochoscopy are biopsy or cytology for the diagnosis of biliary tract malignencies, intrabiliary rupture of hydatid cysts, balloon dilatation of the biliary tract, electrocoagulation, or stent application for biliary malignencies [3, 6, 7, 11, 12, 14, 16, 17, 26, [28] [29] [30] [31] [32] [33] , similar to our study.
The anticipated diagnostic rate of choledochoscopy is between 45.4% and 59%, while the additional unanticipated diagnostic rate is between 29.5% and 31.5% [3, 6] , similar to our results.
Although the mortality and morbidity rates of the operative choledoch exploration are given as 1-5% and 2-17%, respectively [30] , and our results are compatible to the literature data, the prognosis of the choledochoscopy itself is not well known [3] .
In conclusion, choledochoscopy is a reliable procedure in diagnosis and treatment of the hepatopancreatobiliary diseases, particularly in patients in which the other methods are inadequate or unsucessful.
